Abl kinase inhibition

Details for Australian Patent Application No. 2006272609 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Pollar, John

Agent Peter Maxwell & Associates

Pub. Number AU-A-2006272609

PCT Pub. Number WO2007/014250

Priority 60/785,161 23.03.06 US; 60/702,771 26.07.05 US; 60/830,257 12.07.06 US

Filing date 26 July 2006

Wipo publication date 1 February 2007

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/014250 Priority application(s): WO2007/014250

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006272612-Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure

2006272597-Single dose use of CD20-specific binding molecules